Medical Journals

Higher Fasting Plasma Concentrations of Glucagon-like Peptide 1 Are Associated with Higher Resting Energy Expenditure and Fat Oxidation Rates in Humans.

Authors:
  • Pannacciulli Nicola
  • Bunt Joy C
  • Koska Juraj
  • Bogardus Clifton
  • Krakoff Jonathan

From: Obesity and Diabetes Clinical Research Section, Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, AZ 85016, USA. nicolap@mail.nih.gov

The American journal of clinical nutrition

  • Publish Date: Sep 2006
  • ISSN: 0002-9165
  • Volume: 84
  • Issue: 3
  • Pages: 556-60
  • Medium: Print
  • Language: English
  • Citation (JAMA): Pannacciulli Nicola, Bunt Joy C, Koska Juraj, et al. Higher Fasting Plasma Concentrations of Glucagon-like Peptide 1 Are Associated with Higher Resting Energy Expenditure and Fat Oxidation Rates in Humans.. Am. J. Clin. Nutr. Sep 2006;84:556-60

Abstract

BACKGROUND: Glucagon-like peptide 1 (GLP-1) is a gut hormone that decreases appetite and promotes satiety. Its role in energy metabolism regulation is still poorly understood. OBJECTIVE: The aim of the study was to investigate the relation of fasting plasma GLP-1 concentrations to rates of energy expenditure (EE) and substrate oxidation-ie, respiratory quotient (RQ). DESIGN: Forty-six glucose-tolerant white subjects (22 men, 24 women) aged 18-49 y whose adiposity spanned a wide range [body mass index (in kg/m2): 18.5-50] were studied in an inpatient clinic. Main outcome measures included resting EE and RQ (ventilated hood technique), body composition (dual-energy X-ray absorptiometry), and fasting plasma concentrations of GLP-1, pancreatic polypeptide, glucose, and insulin. RESULTS: Fasting plasma GLP-1 concentrations were positively associated with resting EE (after adjustment for age, sex, and body composition) and negatively correlated with RQ (after adjustment for age, sex, and percentage body fat) and fasting plasma pancreatic polypeptide concentrations (both before and after adjustment for age, sex, percentage body fat, and fasting plasma glucose and insulin concentrations). Adjustment for fasting plasma pancreatic polypeptide concentrations, a marker of parasympathetic outflow to the gut, attenuated the strength of the association of fasting plasma GLP-1 concentrations with resting EE and RQ. CONCLUSIONS: Higher fasting plasma GLP-1 concentrations are associated with higher rates of EE and fat oxidation independent of age, sex, and body composition. The autonomic nervous system may have a role in this relation. This effect, along with the established role of GLP-1 in promoting satiety, may further foster its therapeutic potential in the treatment of obesity.

Mesh Headings (Keywords): Absorptiometry, Photon, Adolescent, Adult, Basal Metabolism, Blood Glucose, Body Composition, Dietary Fats, Energy Metabolism, Fasting, Female, Glucagon-Like Peptide 1, Glucose Tolerance Test, Humans, Insulin, Male, Middle Aged, Obesity, Oxidation-Reduction, Oxygen Consumption, Pancreatic Polypeptide


Check for Full Text / PubMed Unique Identifier (PMID): 16960169


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.